These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 11035668
1. Controlled short-term trial of fluticasone propionate in ventilator-dependent patients with COPD. Nava S, Compagnoni ML. Chest; 2000 Oct; 118(4):990-9. PubMed ID: 11035668 [Abstract] [Full Text] [Related]
2. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Lancet; 1998 Mar 14; 351(9105):773-80. PubMed ID: 9519948 [Abstract] [Full Text] [Related]
3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P. Clin Ther; 2006 Jan 14; 28(1):73-85. PubMed ID: 16490581 [Abstract] [Full Text] [Related]
4. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. BMJ; 2000 May 13; 320(7245):1297-303. PubMed ID: 10807619 [Abstract] [Full Text] [Related]
5. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study. Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C. Clin Ther; 2012 Aug 13; 34(8):1655-66.e5. PubMed ID: 22789766 [Abstract] [Full Text] [Related]
6. Controlled trial of inhaled fluticasone propionate in moderate to severe COPD. Thompson WH, Carvalho P, Souza JP, Charan NB. Lung; 2002 Aug 13; 180(4):191-201. PubMed ID: 12391509 [Abstract] [Full Text] [Related]
7. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume. Mouloudi E, Katsanoulas K, Anastasaki M, Hoing S, Georgopoulos D. Intensive Care Med; 1999 Nov 13; 25(11):1215-21. PubMed ID: 10654204 [Abstract] [Full Text] [Related]
8. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause. Mouloudi E, Katsanoulas K, Anastasaki M, Askitopoulou E, Georgopoulos D. Eur Respir J; 1998 Jul 13; 12(1):165-9. PubMed ID: 9701432 [Abstract] [Full Text] [Related]
10. Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness. Langley SJ, Holden J, Derham A, Hedgeland P, Sharma RK, Woodcock A. Chest; 2002 Sep 13; 122(3):806-11. PubMed ID: 12226017 [Abstract] [Full Text] [Related]
11. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC. Am J Respir Crit Care Med; 2002 Jun 15; 165(12):1592-6. PubMed ID: 12070058 [Abstract] [Full Text] [Related]
12. Additive effects of salmeterol and fluticasone or theophylline in COPD. Cazzola M, Di Lorenzo G, Di Perna F, Calderaro F, Testi R, Centanni S. Chest; 2000 Dec 15; 118(6):1576-81. PubMed ID: 11115442 [Abstract] [Full Text] [Related]
13. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Jones PW, Willits LR, Burge PS, Calverley PM, Inhaled Steroids in Obstructive Lung Disease in Europe study investigators. Eur Respir J; 2003 Jan 15; 21(1):68-73. PubMed ID: 12570111 [Abstract] [Full Text] [Related]
14. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ. Chest; 2005 Mar 15; 127(3):851-60. PubMed ID: 15764767 [Abstract] [Full Text] [Related]
15. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD. Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS. Chest; 2007 Dec 15; 132(6):1756-63. PubMed ID: 17951625 [Abstract] [Full Text] [Related]